Risperdal Marketing Appeals Dropped In Pa. Appeals Court

Law360, Philadelphia (September 23, 2013, 6:33 PM EDT) -- Plaintiffs in four bellwether cases seeking to hold marketing firm Excerpta Medica Inc. liable for allegedly assisting Johnson & Johnson to push the antipsychotic drug Risperdal for off-label use in children opted last Monday to withdraw a series of appeals they’d launched in Pennsylvania Superior Court.

The plaintiffs, four men who allegedly grew breasts after taking the drug off-label, each filed requests seeking to have their appeals discontinued after launching bids in December challenging a Philadelphia County judge’s decisions granting summary judgment in favor of the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.